{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:07:29Z","timestamp":1793142449466,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.neuro.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T16:45:36Z","timestamp":1379004336000},"page":"124-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons"],"prefix":"10.1016","volume":"39","author":[{"given":"Nathan P.","family":"Staff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jewel L.","family":"Podratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Grassner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Trushina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Windebank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2013.09.001_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-894X(98)00029-8","article-title":"Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids","volume":"8","author":"Adams","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.neuro.2013.09.001_bib0010","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-10-1950","article-title":"Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events","volume":"17","author":"Arastu-Kapur","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neuro.2013.09.001_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2141.2009.07836.x","article-title":"Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma","volume":"147","author":"Barr","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.neuro.2013.09.001_bib0020","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jpain.2011.04.008","article-title":"Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients","volume":"12","author":"Boyette-Davis","year":"2011","journal-title":"J Pain"},{"key":"10.1016\/j.neuro.2013.09.001_bib0025","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","article-title":"Approval summary for bortezomib for injection in the treatment of multiple myeloma","volume":"10","author":"Bross","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neuro.2013.09.001_bib0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.expneurol.2010.02.006","article-title":"Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice","volume":"223","author":"Bruna","year":"2010","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.neuro.2013.09.001_bib0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.expneurol.2010.09.004","article-title":"Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies","volume":"226","author":"Carozzi","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2013.09.001_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2013.09.001_bib0045","first-page":"pS19","article-title":"Neurophysiological and neuropathological evaluation of the bortezomib effect in myeloma-bearing mice","author":"Ceresa","year":"2011","journal-title":"J Peripheral Nervous Sys"},{"key":"10.1016\/j.neuro.2013.09.001_bib0050","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI1130","article-title":"Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle","volume":"101","author":"Gill","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuro.2013.09.001_bib0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuro.2013.05.008","article-title":"Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy","volume":"37","author":"LaPointe","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2013.09.001_bib0060","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/mus.23493","article-title":"A case of peripheral nerve microvasculitis associated with multiple myeloma and bortezomib treatment","volume":"46","author":"Mauermann","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuro.2013.09.001_bib0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpain.2009.07.001","article-title":"Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats","volume":"14","author":"Meregalli","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.neuro.2013.09.001_bib0070","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.nbd.2010.11.017","article-title":"Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons","volume":"41","author":"Podratz","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2013.09.001_bib0075","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4161\/cc.7.7.5625","article-title":"Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition","volume":"7","author":"Poruchynsky","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuro.2013.09.001_bib0080","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2005.04.7779","article-title":"Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib","volume":"24","author":"Richardson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neuro.2013.09.001_bib0085","first-page":"1065","article-title":"Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells","volume":"26","author":"Scuteri","year":"2006","journal-title":"Anticancer Res"},{"issue":"16","key":"10.1016\/j.neuro.2013.09.001_bib0160","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/glia.21065","article-title":"Pathological adaptive responses of Schwann cells to endoplasmic reticulum stress in bortezomib-induced peripheral neuropathy","volume":"58","author":"Shin","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.neuro.2013.09.001_bib0095","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.0b013e31821103f7","article-title":"Neuronal intracellular transport and neurodegenerative disease","volume":"76","author":"Staff","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2013.09.001_bib0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbadis.2009.09.013","article-title":"Abnormal mitochondrial dynamics and neurodegenerative diseases","volume":"1802","author":"Su","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuro.2013.09.001_bib0105","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","article-title":"Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding","volume":"27","author":"Ta","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2013.09.001_bib0110","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1002\/j.1460-2075.1994.tb06878.x","article-title":"A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B","volume":"13","author":"Traenckner","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.neuro.2013.09.001_bib0115","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neuro.2013.09.001_bib0120","doi-asserted-by":"crossref","first-page":"e32737","DOI":"10.1371\/journal.pone.0032737","article-title":"Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease","volume":"7","author":"Trushina","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuro.2013.09.001_bib0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.pharmtox.46.120604.141300","article-title":"The proteasome and proteasome inhibitors in cancer therapy","volume":"46","author":"Voorhees","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neuro.2013.09.001_bib0130","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer's disease","volume":"29","author":"Wang","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2013.09.001_bib0135","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuro.2013.09.001_bib0140","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.44.3_Part_1.488","article-title":"The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro","volume":"44","author":"Windebank","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2013.09.001_bib0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2012.08.023","article-title":"Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy","volume":"238","author":"Zheng","year":"2012","journal-title":"Exp Neurol"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X13001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X13001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T21:38:38Z","timestamp":1563917918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X13001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":29,"alternative-id":["S0161813X13001496"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2013.09.001","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}